https://www.marketscreener.com/quote/stock/ANAVEX-LIFE-SCIENCES-CORP-24735935/news/Anavex-Presents-31-Week-Safety-Data-from-Phase-2a-Study-of-ANAVEX-2-73-in-Alzheimer-s-Patients-at-22742181/?utm_source=telegram&utm_medium=social&utm_campaign=share